LEVI STRAUSS & CO — Director's Dealing 2023

Apr 21, 2023

SEC Form 4/A — Form 4/A

Issuer: LEVI STRAUSS & CO (LEVI)
CIK: 0000094845
Period of Report: 2019-03-25

Reporting Person: JAFFE SETH (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-25	Common Stock	J	228480	$0.00	Disposed	52800	Direct
2019-03-25	Common Stock	J	52800	$0.00	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-25	Class B Common Stock	$	J	228480	Acquired		Class A Common Stock (228480)	Direct
2019-03-25	Class B Common Stock	$	J	52800	Acquired		Class A Common Stock (52800)	Direct
2019-03-25	Stock Appreciation Rights	$6.10	J	453320	Disposed	2023-02-09	Common Stock (453320)	Direct
2019-03-25	Stock Appreciation Rights	$6.10	J	453320	Acquired	2023-02-09	Class B Common Stock (453320)	Direct
2019-03-25	Stock Appreciation Rights	$7.425	J	339610	Disposed	2022-02-04	Common Stock (339610)	Direct
2019-03-25	Stock Appreciation Rights	$7.425	J	339610	Acquired	2022-02-04	Class B Common Stock (339610)	Direct
2019-03-25	Stock Appreciation Rights	$6.45	J	279560	Disposed	2021-02-05	Common Stock (279560)	Direct
2019-03-25	Stock Appreciation Rights	$6.45	J	279560	Acquired	2021-02-05	Class B Common Stock (279560)	Direct
2019-03-25	Stock Appreciation Rights	$14.875	J	44720	Disposed	2029-01-29	Common Stock (44720)	Direct
2019-03-25	Stock Appreciation Rights	$14.875	J	44720	Acquired	2029-01-29	Class B Common Stock (44720)	Direct
2019-03-25	Stock Appreciation Rights	$9.60	J	74120	Disposed	2025-01-30	Common Stock (74120)	Direct
2019-03-25	Stock Appreciation Rights	$9.60	J	74120	Acquired	2025-01-30	Class B Common Stock (74120)	Direct
2019-03-25	Stock Appreciation Rights	$6.90	J	108490	Disposed	2024-02-01	Common Stock (108490)	Direct
2019-03-25	Stock Appreciation Rights	$6.90	J	108490	Acquired	2024-02-01	Class B Common Stock (108490)	Direct

Footnotes

F1: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F2: This Form 4/A is being filed to correct the disclosure relating to RSUs set forth in the Form 4 filed on March 27, 2019 (the "Original Form 4"), which were inadvertently disclosed in Table I instead of Table II in the Original Form 4. As a result, certain subsequent instances of withholding of shares to satisfy tax liabilities were reported solely within Table I.

F3: Each share is represented by a restricted stock unit (RSU) that may be settled in shares of Class B Common Stock. Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Of these RSUs, (i) 24,230 RSUs vest on February 1, 2020, (ii) 15,130 RSUs vest in four equal annual installments beginning on January 30, 2019, and (iii) 13,440 RSUs vest in four equal annual installments beginning on January 30, 2020.

F4: Each stock appreciation right (SAR) represents the right to receive, upon exercise, shares of the Issuer's Common Stock (and, after the conversion noted in footnote (1), Class B Common Stock) with a value equal to the increase in the fair market value of one share of such stock from the date of grant of the SAR.

F5: Of these SARs: (i) 206,050 are performance stock appreciation rights (PSARs) that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 247,270 SARs that vested as to 25% of the SARs on February 9, 2017, with the remainder vesting in 36 equal monthly installments thereafter.

F6: Of these SARs: (i) 144,430 are PSARs that vested on January 30, 2018 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 195,180 SARs that are fully vested.

F7: Of these SARs: (i) 93,190 are PSARs that vested on February 1, 2017 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 186,370 SARs that are fully vested.

F8: 25% of the SARs vest on January 30, 2020, and 1/3 of the remaining SARs vest annually beginning on January 30, 2021.

F9: 25% of the SARs vested on January 30, 2019, and 1/3 of the remaining SARs vest annually beginning on January 30, 2020.

F10: 25% of the SARs vested on February 1, 2018, and 1/3 of the remaining SARs vest annually beginning on February 1, 2019.